U.S. Tobacco Stock News

If you are wondering whether GoDaddy's current share price lines up with its underlying worth, you are not alone. This article is built to help you think that through clearly. GoDaddy shares last closed at US$93.95, with a 7 day return of 7.8%, a 30 day return of 1.8% decline, a year to date return of 20.7% decline, a 1 year return of 46.4% decline, a 3 year return of 29.8% and a 5 year return of 29.7%. Recent moves in the share price have put more attention on how the market is currently...

In 2025, Ryan Specialty Holdings Inc. reported a 21.3% increase in total revenue to over US$3.05 billion, completed five acquisitions expected to add more than US$125 million in annualized revenue, and launched the three-year Empower Program restructuring to streamline operations and target annual savings of US$80 million by 2029. This combination of strong top-line expansion, acquisition-driven scale in its Underwriting Management specialty, and a multi-year cost-efficiency plan highlights...

If you are wondering whether Kratos Defense & Security Solutions is priced for perfection or still offers value, it helps to step back and look at the numbers through a few different valuation lenses. The stock recently closed at US$87.00, with returns of 1.0% over the last week, a 4.7% decline over 30 days, 9.7% year to date, around 220% over one year and a very large gain over three years that is close to 7x, as well as 228.1% over five years, which can change how investors think about...

If you are wondering whether Molina Healthcare's current share price lines up with its underlying value, you are not alone. That is exactly what this article will unpack. Molina Healthcare's share price closed at US$144.47, with returns of 6.2% decline over 7 days, 18.9% decline over 30 days, 19.0% decline year to date, 55.9% decline over 1 year, 44.7% decline over 3 years, and 37.9% decline over 5 years that may have changed how some investors view its risk and potential. Recent news flow...

Aktis Oncology (NasdaqGS:AKTS) received FDA Fast Track designation for AKY-1189 in advanced urothelial cancer. The designation aims to support faster clinical development and regulatory review for this radiopharmaceutical candidate. The company also provided updates on the ongoing NECTINIUM-2 Phase 1b trial of AKY-1189. Aktis Oncology focuses on radiopharmaceutical therapies, targeting cancers that can be difficult to treat with existing options. For investors watching NasdaqGS:AKTS, the...

IHS Holding (NYSE:IHS) has agreed to be acquired by MTN Group in an all cash transaction. The merger agreement has received full approval from the IHS Holding Board. The deal offers shareholders immediate liquidity with a premium to the recent trading price. The announcement comes during a period of challenging market and geopolitical conditions for tower operators. IHS Holding runs telecom tower infrastructure across multiple emerging markets, giving mobile operators shared access to...

If you are wondering whether Kraft Heinz shares are quietly offering value or still carrying old baggage, you are in the right place to unpack what the current price really implies. The stock closed at US$24.54 recently, with returns of 0.2% over 30 days and 0.6% year to date, while the 1 year return of an 18.9% decline and 3 year return of a 24.4% decline may have tested long term holders' patience. Recent news around Kraft Heinz has largely focused on how the company is reshaping its...

If you are wondering whether Travelers Companies at around US$306 per share still offers reasonable value, you are not alone. This article is designed to help you weigh what the current price might be implying. The stock has been relatively steady in the very short term with a 0.8% decline over the last 7 days, while the 30 day, year to date and 1 year returns of 3.8%, 7.4% and 20.8% give a fuller picture of how the market has been pricing it recently. Alongside these moves, investors have...

In February 2026, Dominion Energy reported past fourth-quarter 2025 sales of US$4,093 million and net income of US$567 million, alongside full-year 2025 sales of US$16.51 billion and net income of US$3.00 billion, and issued 2026 operating earnings guidance of US$3.45–US$3.69 per share. An important angle for investors is Dominion’s decision to significantly lift its 2026–2030 capital spending to US$64.70 billion to meet surging, data center-driven electricity demand from major technology...

Limbach Holdings (NasdaqCM:LMB) is relocating its corporate headquarters to Tampa, Florida in its 125th anniversary year. The company is aligning its senior leadership and a growing share of its workforce around the Tampa area. The move accompanies ongoing acquisitions and a sharpened focus on national vertical markets, including healthcare, data centers, and industrial manufacturing. Limbach Holdings operates as a building systems solutions provider, with services that span mechanical,...

Aurinia Pharmaceuticals reported four consecutive quarters of positive earnings surprises alongside improved profitability. Recent updates highlight strong sales performance and higher operating margins, supported by a solid financial position. The company, listed as NasdaqGM:AUPH, continues to show resilience within a competitive pharmaceutical sector. Aurinia Pharmaceuticals, trading on NasdaqGM:AUPH, is drawing attention after a run of four straight positive earnings surprises paired...

Riot Platforms has acquired full ownership of its Rockdale data center campus, removing future rent obligations. The company has signed a 10 year data center lease with AMD, positioning Rockdale as an anchor facility for high performance computing and AI workloads. This marks a pivot for NasdaqCM:RIOT from being focused mainly on Bitcoin mining to operating as a broader digital infrastructure and data center provider. For investors who know Riot Platforms mainly as a Bitcoin miner, this...

In late February 2026, Catalyst Pharmaceuticals reported fourth quarter 2025 revenue of US$152.61 million and full-year 2025 revenue of US$588.99 million, alongside earnings guidance for full-year 2026 of US$615 million to US$645 million. These results highlight how expanding rare-disease franchises like FIRDAPSE and AGAMREE are becoming increasingly important profit drivers for the company. We’ll now examine how Catalyst’s raised 2026 revenue outlook reshapes its existing investment...

Fortinet reported strong Q4 results that were ahead of expectations on both revenue and earnings. The company outlined an upbeat billings outlook for fiscal 2026 that is above prior consensus views. Management highlighted growing momentum in Fortinet’s Secure Access Service Edge, or SASE, offerings as a key driver. Fortinet, listed as NasdaqGS:FTNT, is drawing fresh attention after its latest quarterly update, which put a spotlight on both its core security franchise and its growing SASE...

If you are wondering whether Tempus AI's share price reflects its underlying worth, you are not alone. Many investors are asking the same question as the story around this stock matures. Tempus AI recently closed at US$52.26, with returns of a 1.9% decline over 7 days, a 2.4% decline over 30 days and a 16.2% decline year to date, set against a 6.4% gain over the past year. Recent coverage has focused on Tempus AI's position in applying AI tools to healthcare decision making and how that...

Energizer Holdings (NYSE:ENR) is under pressure following a sector wide sell off in consumer staples. The move is linked to rising geopolitical tensions and renewed inflation concerns affecting equity markets. Investors are reassessing near term risk for battery and household product makers as volatility increases. Energizer Holdings, known for its batteries and household products, is getting fresh attention as consumer staples stocks react to macro headlines. With geopolitical tensions in...

If you are wondering whether Madrigal Pharmaceuticals' current share price reflects its potential, you are not alone. This article will focus squarely on what the numbers say about value. The stock closed at US$432.83, with returns of 0.2% over the past week, a 9.6% decline over 30 days, a 27.1% decline year to date, a 30.6% return over 1 year and a 79.1% return over 3 years, alongside a very large 5-year gain of around 3.7x. These mixed recent returns have come as investors absorb ongoing...

If you are wondering whether PPG Industries' current share price really reflects what the business is worth, you are not alone. That is exactly what this article will tackle. PPG shares most recently closed at US$106.70, with returns of a 13.4% decline over the past 7 days, a 15.3% decline over 30 days, a 2.3% gain year to date, and a 5.2% decline over 1 year, alongside a 9.5% decline over 3 years and an 18.8% decline over 5 years. Recent coverage of PPG has focused on its position as a...

Victory Capital Management has increased its stake in Altria Group (NYSE:MO), signaling fresh institutional interest in the tobacco company. The move comes as Altria continues to operate under persistent regulatory and public health scrutiny affecting the broader tobacco sector. This change in ownership arrives while recent discussions focus on dividend sustainability and reaffirmed guidance from the company. Altria, the parent company behind Marlboro cigarettes in the US, sits at the...

How Kroger's FY 2026 Numbers Set the Stage Kroger (KR) closed FY 2026 with fourth quarter revenue of US$34.7 billion and EPS of US$1.37, alongside net income of US$861 million as investors weighed the full year picture. Over the past year, revenue in the reported quarters ranged from US$33.7 billion to US$45.1 billion, while quarterly EPS swung between a loss of US$2.02 and a high of US$1.37, with trailing twelve month EPS at US$1.56 reflecting that volatility. With trailing net margins...

Recent performance and business snapshot With no single headline event driving attention to Johnson Controls International (JCI), investors are focusing on the stock’s recent moves and the scale of its building solutions business. The share price closed at $132.40, with a 1 day return of a 3.48% decline and a 7 day return of an 8.25% decline. Over the past month the stock shows a 2.25% gain, and over the past 3 months a 15.91% gain. The company reports annual revenue of $23.97b and net income...

Cintas recently moved above its 200-day moving average and received a Zacks Rank #2 (Buy), supported by upward revisions to earnings estimates and no recent downward changes. This combination of strengthening technical signals and improving earnings expectations points to rising investor confidence in how Cintas is positioned within its industry. Now, we’ll examine how this earnings-upgrade-driven momentum might influence Cintas’ investment narrative built around quality compounding and...

Macy’s, Inc. recently declared a regular quarterly dividend of US$0.1915 per share on its common stock, a 5% increase, payable on April 1, 2026, to shareholders of record as of March 13, 2026. Alongside this dividend increase, Macy’s upcoming March 18 earnings release is drawing attention as investors gauge management’s confidence amid inflation-pressured consumer spending. We’ll explore how the recent 5% dividend increase may influence Macy’s investment narrative ahead of its forthcoming...

Earlier this week, online travel agencies rallied after reports that OpenAI is scaling back plans for direct travel bookings inside ChatGPT, opting instead to prioritize partnerships with established intermediaries. This pivot reduces concerns that AI could bypass platforms like Tripadvisor entirely, highlighting the continuing role of specialized travel infrastructure and curated content in complex trip planning. We’ll now examine how OpenAI’s renewed focus on partnerships, rather than...